Connected Apps for Digital Therapeutics

Get your patients started with FDA cleared digital therapeutics with the Glooko platform.

Advisor Pro

Third party decision support tool for pump optimization which can help clinicians and patients optimize insulin pump settings.

Ideal for:

  • Patients diagnosed with type 1 diabetes
  • Uses insulin therapy via a Glooko compatible insulin pump
  • Utilizes a Glooko compatible continuous glucose monitor

Mobile Insulin Dosing System (MIDS)

Develop and manage a long-acting insulin titration program for your patients with the Glooko mobile app.

Ideal for:

  • Patients diagnosed with type 2 diabetes
  • Optimizing new or existing long acting insulin dosing
  • Dynamic patient engagement via mobile app

Insulin Insights™

Third party decision support software manages all combinations of insulin and generates injection-specific titration recommendations for each patient.

Ideal for:

  • Patients diagnosed with type 2 diabetes
  • Optimizing new or existing insulin regimen
  • Support any insulin type, preparation, or combined regimen

Advisor Pro

Third party decision support tool for pump optimization which can help clinicians and patients optimize insulin pump settings.

Mobile Insulin Dosing System (MIDS)

Develop and manage a long-acting insulin titration program for your patients with the Glooko mobile app.

Insulin Insights™

Third party decision support software manages all combinations of insulin and generates injection-specific titration recommendations for each patient.

Ideal for:

  • Patients diagnosed with type 1 diabetes
  • Uses insulin therapy via a Glooko compatible insulin pump
  • Utilizes a Glooko compatible continuous glucose monitor

Ideal for:

  • Patients diagnosed with type 2 diabetes
  • Optimizing new or existing long acting insulin dosing
  • Dynamic patient engagement via mobile app

Ideal for:

  • Patients diagnosed with type 2 diabetes
  • Optimizing new or existing insulin regimen
  • Support any insulin type, preparation, or combined regimen

MKT-0212 01 06/20